Contemporary diagnostic practice in psychiatry relies on the tick-box approach of diagnostic manuals. In light of the obvious limitations of diagnostic systems, narrative formulations, whether in the form of biological, psychodynamic or behavioural cognitive ones, have been proposed. Their approach, which can be caricatured as one of drawing arrows, enriches our clinical tools and practice but in their explicitly theoretical orientation, as well as expanding the field of discovery, they also constrain it. In two previous papers I summarized the resulting limitations, with specific reference to the patient’s experience and proposed further enriching clinical perspicacity by attending to images and parataxis. The specific intent of attending to the patient’s experiences through a process that explicitly eschews narrativization, but allows clinical phenomena to “hang loose”, is to facilitate a process of clinical discovery and healing through practices of co-production between patient and clinician. In the present paper, I expand the range of phenomena that may assist in this co-production through adding attention to dreams to that of images and parataxis. In particular, I turn to the work of the Italian novelist Guido Morselli. Morselli agrues that the self is created through bundling experiences together through acts of “will” in order to establish our personal narrative. In doing so, however, the “will” forbids access to phenomena that do not fit the dominant narrative. Experience is therefore impoverished. Dream consciousness is a type of consciousness not harnessed by the constraints of narrativity. It allows a slipping of the narrative vigilance which bundles phenomena together to create a coherent narrative and thus offers a richer menu of potential experiences, including “bizarre” images that can serve to challenge our usual self-narrative and offer a new perspective on ourselves.

: The interaction of the Activating Transcription Factor 6 (ATF6), a key effector of the unfolded protein response (UPR) in the endoplasmic reticulum, with the neuronal calcium sensor Downstream Regulatory Element Antagonist Modulator (DREAM) is a potential therapeutic target in neurodegeneration. Modulation of the interaction ATF6-DREAM with repaglinide (RP) induced neuroprotection in a model of Huntington´s disease. Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder with no cure, characterized by the progressive loss of motoneurons resulting in muscle denervation, atrophy, paralysis and death. The aim of this work was to investigate the potential therapeutic significance of DREAM as a target for intervention in ALS. We found that the expression of the DREAM protein was reduced in the spinal cord of SOD1G93A mice compared to wild type littermates. RP treatment improved motor strength and reduced the expression of the ALS progression marker collagen type XIX1 (Col191 mRNA) in the quadriceps muscle in SOD1G93A mice. Moreover, treated SOD1G93A mice showed reduced motoneuron loss and glial activation and increased ATF6 processing in the spinal cord. These results indicate that the modulation of the DREAM-ATF6 interaction ameliorates ALS symptoms in SOD1G93A mice.

Several mathematicians and physicists are working all over the globe to get a unified theory. However, most of them are discarding Einstein’s view at the very first step of their theories. This article provides a brief description about this. Also, on the basis of Koga’s theory we point out two reasons which might have caused Einstein’s failure to get a unified theory.